MedWatch

Banks thrilled by Swedish medtech company

A Swedish medtech group is praised by Goldman Sachs, who shows renewed interest in the share of the company, while a Danish major bank lauds the huge growth potential of the share.

Foto: Nordea

The share of the Swedish medtech company Elekta, which manufactures radiation equipment for cancer treatment, was up this Tuesday after Goldman Sachs added it to its list of preferred shares and resumed coverage.

Goldman Sachs sees Elekta as the strongest share in the European medtech industry, according to a new analysis from the American bank. The reason is a high demand on radiation treatment, for which the bank estimates a market growth of 6 % a year from 2012 to 2017.

Allerede abonnent? Log ind.

Læs hele artiklen

Få adgang i 14 dage for 0 kr.
Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.

  • Adgang til alle låste artikler
  • Modtag vores daglige nyhedsbreve
  • Fuld adgang til vores app
Der skete en fejl. Prøv venligst igen senere

Få fuld adgang til dig og dine kollegaer.

Start et gratis virksomhedsprøveabonnement

Mere fra MedWatch

Dansk Biotek skifter navn

Den danske brancheorganisation for biotekselskaber, Dansk Biotek, skifter navn til "Danish Bio - Dansk Biotek" for at imødekomme den stigende internationalisering af branchen, fortæller formand.

Seneste nyt

MedWatch job

Se flere jobs

Se flere jobs

Watch job

Se flere jobs

Se flere jobs

Latest news

Seneste nyt fra Watch Medier